December 4, 2020

Volume X, Number 339

Advertisement

December 03, 2020

Subscribe to Latest Legal News and Analysis

December 02, 2020

Subscribe to Latest Legal News and Analysis

December 01, 2020

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
9
Oct
Canada Sets Import Conditions for US Romaine Lettuce Keller and Heckman LLP
8
Oct
European Parliament Calls on EC to Ban Titanium Dioxide (E171) in Food Bergeson & Campbell, P.C.
8
Oct
Organic Interests Contest USDA Certification of Hydroponics Keller and Heckman LLP
8
Oct
DEA Proposes Regulations for Emergency Medical Services Agencies McDermott Will & Emery
8
Oct
Focus on Life Sciences: After the Curve [PODCAST] McDermott Will & Emery
7
Oct
October 2020 Talc Lawsuit Update: Johnson & Johnson Agrees to Pay $100 Million Settlement Console and Associates, P.C.
7
Oct
SEC Continues to Prioritize COVID Fraud Cases Faegre Drinker
7
Oct
Suspension of Employee Based on Marijuana Odor and Positive Test Result Did Not Violate CBA Jackson Lewis P.C.
7
Oct
Court Gives Vanilla Ice Cream False Advertising Claims a Frosty Reception Proskauer Rose LLP
7
Oct
FDA and Mexico Strengthen Food Safety Partnership by Signing Statement of Intent Keller and Heckman LLP
6
Oct
FDA Will Hold NanoDay Virtual Research Symposium on October 9 Bergeson & Campbell, P.C.
6
Oct
Federal Circuit Finds Recombinant Polypeptide Anticipated By Native Polypeptide Foley & Lardner LLP
5
Oct
U.S. Supreme Court to Hear ERISA Preemption Dispute Jackson Lewis P.C.
5
Oct
California Becomes First State to Ban 24 Ingredients from Cosmetics and Personal Care Products Mintz
5
Oct
FDA’s Prescription Drug Advertising Enforcers Issue COVID-19-Related Warning Letter Mintz
5
Oct
FDA Announces Three Dates for Public Meetings to Discuss the Proposed Rule for Additional Traceability Records for Certain Foods Keller and Heckman LLP
2
Oct
USDA Announces Funding Through The Biorefinery, Renewable Chemical, And Biobased Product Manufacturing Program Bergeson & Campbell, P.C.
2
Oct
EPA Extends Public Comment Period On ICR On Anaerobic Digestion Facilities Processing Wasted Food Bergeson & Campbell, P.C.
2
Oct
FDA Releases Results on Sampling of “Dairy-Free” Dark Chocolate for Milk Allergen Keller and Heckman LLP
2
Oct
FDA’s Proposed Rule on “Intended Use” Confirms Agency Will Rely on “Any Relevant Source” of Evidence Sheppard, Mullin, Richter & Hampton LLP

Pages

Advertisement
Advertisement

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Tuesday, December 8, 2020
Wednesday, December 9, 2020
Wednesday, December 9, 2020
Wednesday, December 9, 2020
Thursday, December 10, 2020
Thursday, December 10, 2020
Thursday, December 17, 2020
Advertisement